ABRE Clinical Study of the Abre Venous Self | 合法醫療器材資訊網

Read More

DUBLIN , Oct. 26, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug ... Read More

2020年11月10日 — PMA Applicant: Medtronic Vascular, Inc. Address: 3033 Campus Drive, Plymouth, MN, 55441. Approval Date: October 21, 2020. Approval Letter: ... Read More

2020年10月26日 — Medtronic today announced it has received US Food and Drug Administration (FDA) approval for the Abre venous self-expanding stent system. Read More

Iliofemoral Venous Obstruction, Device: Abre venous self-expanding stent system ... to give written informed consent and/or to comply with study procedures. Read More

2020年10月27日 — Medtronic has received U.S. Food and Drug Administration (FDA) approval for the Abre venous self-expanding stent system. Read More

2020年10月26日 — Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for the Abre venous self-expanding stent system. Read More

2020年10月26日 — Medtronic has been awarded FDA approval for a device that treats venous outflow obstruction. The Dublin-based company's Abre venous ... Read More

2020年10月27日 — Medical technology firm Medtronic has secured approval from the US Food and Drug Administration (FDA) for its Abre venous self-expanding ... Read More